First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

Monday, March 30, 2020 1 min read

Key Takeaway: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

Full Press Release Details

First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19.